[ACRS] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
25-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 66.39%
YoY- 51.77%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 7,753 1,501 1,580 1,095 3,669 999 0 -
PBT -27,635 -22,804 -13,779 -19,177 -38,551 -24,764 -11,475 15.76%
Tax 5,656 2,003 -182 -32,181 -958 -1,830 -40 -
NP -33,291 -22,804 -13,173 -18,594 -38,551 -22,934 -11,475 19.41%
Tax Rate - - - - - - - -
Total Cost 41,044 24,305 14,753 19,689 42,220 23,933 11,475 23.65%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -429.40 -1,519.25 -833.73 -1,698.08 -1,050.72 -2,295.70 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.50 -0.37 -0.30 -0.45 -0.99 -0.74 -0.49 0.33%
EPS Diluted -0.50 -0.37 -0.30 -0.45 -0.99 -0.74 -0.49 0.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.